Q1 EPS Estimates for DENTSPLY SIRONA Decreased by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Research analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for shares of DENTSPLY SIRONA in a report released on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will post earnings of $0.29 per share for the quarter, down from their prior estimate of $0.32. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q2 2025 earnings at $0.43 EPS, Q3 2025 earnings at $0.48 EPS, Q4 2025 earnings at $0.53 EPS, FY2025 earnings at $1.73 EPS, FY2026 earnings at $1.94 EPS, FY2027 earnings at $2.28 EPS and FY2028 earnings at $2.60 EPS.

Other equities research analysts have also recently issued reports about the company. Evercore ISI reiterated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Wells Fargo & Company dropped their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Finally, Mizuho decreased their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Thirteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $22.58.

DENTSPLY SIRONA Trading Up 1.4 %

NASDAQ XRAY traded up $0.17 during trading hours on Friday, hitting $12.72. 924,121 shares of the company were exchanged, compared to its average volume of 2,942,307. The stock has a market cap of $2.54 billion, a PE ratio of -6.14, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a 50-day moving average price of $15.95 and a 200 day moving average price of $18.96. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $31.13.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 5.03%. DENTSPLY SIRONA's payout ratio is -14.07%.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.52% of the company's stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MML Investors Services LLC boosted its position in shares of DENTSPLY SIRONA by 2.1% during the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier's stock worth $803,000 after buying an additional 620 shares during the period. Y Intercept Hong Kong Ltd increased its position in DENTSPLY SIRONA by 28.8% during the third quarter. Y Intercept Hong Kong Ltd now owns 30,823 shares of the medical instruments supplier's stock worth $834,000 after buying an additional 6,899 shares during the last quarter. Barclays PLC boosted its position in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares during the period. M&T Bank Corp grew its stake in DENTSPLY SIRONA by 5.6% in the 3rd quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier's stock valued at $1,058,000 after buying an additional 2,062 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $261,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.